Introducing BiologicPatentWatch: Biotechnology Industry Competitive Intelligence
After months of development, BiologicPatentWatch.com is live.
Building on the framework of DrugPatentWatch, BiologicPatentWatch provides comprehensive details on FDA approved biologic drugs, developers and patents. The integrated databases allow both freeform searching and dynamic browsing, making it easy to find information on drug patents both in the US and internationally, Orphan Drug Status, trends in patent expirations and more …
BiologicPatentWatch concentrates deep knowledge on biologic drugs from more than 60 biotechnology companies, including more than 2,800 active and expired US patents and 41,000 international patents spanning 91 countries and regional patent offices.
BiologicPatentWatch complements DrugPatentWatch’s focus on small molecule drugs, and provides comprehensive information on:
- monoclonal antibodies
- cytokines, growth factors, enzymes, immunomodulators; and thrombolytics
- proteins intended for therapeutic use that are extracted from animals or microorganisms, including recombinant versions of these products (except clotting factors)
- other non-vaccine therapeutic immunotherapies